In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.


on Acute Coronary Syndromes

Focus on Acute Coronary Syndromes

Acute coronary syndrome (ACS) is a continuum with different forms of presentation, clinical contexts, electrocardiographic parameters and biomarkers. However, most of the diagnostic and intervention strategies are similar in all of them.

While invasive management is recommended in all ACS cases (with few exceptions), its timing varies according to the risk of the patient.

Antithrombotic therapy is a cornerstone to managing ACS. While there is a default strategy for all patients, some alternatives are available according to the bleeding and ischaemic risk of the patients during the year following the index event.

Long-term interventions are key to improving the long-term prognosis of patients with ACS. State-of-the-art management of ACS must include patients in decision making throughout the process.

The content below, selected by Ronen Beeri, Robert Byrne, Borja Ibanez, Margret Leosdottir, JJ Coughlan, and Maria Rubini Gimenez, will help you expand your knowledge of acute coronary syndromes. 



ESC 2023 Clinical Practice Guidelines Webinars

What’s new in treating acute coronary syndrome: an overview
8 November 2023
With Robert Byrne, Borja Ibanez and Vijay Kunadian

Management of multivessel disease
15 November 2023
With Borja Ibanez, Colin Berry, and JJ Coughlan 

Most recent changes on management of MINOCA
22 November 2023
With Vijay Kunadian, Mary Galbraith and Maria Rubini Gimenez

Antithrombotic strategy for ACS: from default to alternative strategies
28 November 2023
With Robert Byrne, Francisco Javier, and Pascal Vranckx


Dig deeper

Exclusive for members

 ACVC Biomarker Talk Series - Rapid diagnostic algorithms for NSTEMI

 Reducing risk in the post-MI patient

 Introduction: Guidelines in Practice: myocardial infarction with nonobstructive coronary artery disease

 What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge. Glucose-lowering medication after myocardial infarction:

 What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge. Take-home messages: glucose-lowering medication after myocardial infarction in hospital and after discharge.

 Proposal for a standardised discharge letter after hospital stay for acute myocardial infarction

 Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology

 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group

 Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis

 Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II)

 Is the contemporary care of the older persons with acute coronary syndrome evidence-based?